ClinicalTrials.gg
CompletedNCT07869862PILATES-FMSUpdated Oct 16, 2026

Effects of 8-Week Mat Pilates and Reformer Pilates Exercises on Functional Movement Screen Scores and Joint Range of Motion in Recreationally Active Males

An interventional study of Reformer Pilates Training and Mat Pilates Training in Healthy Volunteers and Physical Fitness, sponsored by Tokat Gaziosmanpasa University. Completed at 1 site in Turkey (Türkiye). Open to male participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-16.

Sponsored by Tokat Gaziosmanpasa University · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Apr 2026, registered Oct 2026).
Updated Oct 13, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
18 Years to 25 Years
Sex
Male
01

Study summary

The goal of this clinical trial is to compare how 8 weeks of Mat Pilates and Reformer Pilates affect movement quality and joint flexibility in active young men. The main questions it aims to answer are:

Does Mat Pilates or Reformer Pilates improve whole-body movement scores measured by the Functional Movement Screen (FMS)? Does Mat Pilates or Reformer Pilates increase joint flexibility (range of motion) in the hips, shoulders, and ankles? Researchers will compare Mat Pilates, Reformer Pilates, and an inactive control group to see if one type of Pilates works better than the other.

Participants will:

Complete movement quality tests and joint flexibility measurements before and after the 8-week period.

Take part in structured Mat Pilates or Reformer Pilates exercise sessions for 8 weeks, or continue their usual daily activities without Pilates (control group).

Read the detailed description

Pilates exercises are widely utilized to enhance core stability, postural control, and neuromuscular coordination. However, evidence directly comparing equipment-based (Reformer) and floor-based (Mat) Pilates interventions on movement patterns and mobility in active males is limited.

Thirty-six recreationally active male participants were randomly allocated into three equal parallel groups:

Reformer Pilates Group: Performed progressive reformer-based exercise sessions (3 days per week, 8 weeks).

Mat Pilates Group: Performed progressive mat-based exercise sessions (3 days per week, 8 weeks).

Control Group: Maintained habitual daily activities without engaging in structured exercise training.

Assessments were conducted at baseline and at the conclusion of the 8-week period. Primary outcomes included composite and subtest scores of the Functional Movement Screen (FMS). Secondary outcomes included active joint range of motion (ROM) of the shoulder, hip, and ankle joints, alongside body composition parameters (body weight, BMI, body fat percentage, and fat-free mass).

02

Conditions studied

  • Healthy Volunteers
  • Physical Fitness

Keywords

  • Pilates
  • Functional Movement Screen
  • Range of Motion
  • Health
  • Reformer Pilates
  • Mat Pilates
03

In context

Lead sponsor

Tokat Gaziosmanpasa University is the lead sponsor of 170 studies on the registry; 38 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy recreationally active males aged 18 to 25 years
  • Regularly engaging in recreational physical activity (at least 2-3 days per week)
  • Voluntarily agreeing to participate and providing signed informed consent

Exclusion criteria

Exclusion Criteria:

  • Any history of musculoskeletal injury or orthopedic surgery within the last 6 months
  • Chronic cardiovascular, metabolic, or neurological disorders
  • Prior formal training experience in Mat or Reformer Pilates within the past 6 months
  • Inability to complete the 8-week exercise intervention or assessment sessions
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
36 participants (actual)

Study arms

  • Experimental
    Experimental

    Participants completed progressive reformer-based Pilates exercise sessions for 8 weeks (3 sessions per week).

    Behavioral: Reformer Pilates Training

  • Active comparator
    Mat Pilates Group

    Participants completed progressive mat-based Pilates exercise sessions for 8 weeks (3 sessions per week).

    Behavioral: Mat Pilates Training

  • No intervention
    Control Group

    Participants maintained their habitual physical activities and did not engage in any structured exercise training during the 8-week period.

Interventions

  • BehavioralReformer Pilates Training

    A structured 8-week progressive equipment-based Reformer Pilates training protocol conducted 3 days per week (approximately 50-60 minutes per session).

  • BehavioralMat Pilates Training

    A structured 8-week progressive floor-based Mat Pilates training protocol conducted 3 days per week (approximately 50-60 minutes per session).

06

What researchers measure

Primary outcomes

  1. Change from Baseline in Functional Movement Screen (FMS) Composite Score

    Functional movement quality assessed via Functional Movement Screen (FMS) consisting of 7 subtests (deep squat, hurdle step, in-line lunge, shoulder mobility, active straight-leg raise, trunk stability push-up, and rotary stability). Each subtest is scored on an ordinal scale from 0 to 3 points. When bilateral testing was conducted, the lower score was recorded. Scores of all seven subtests are aggregated/summed to calculate a total composite score ranging from 0 to 21 points. Higher composite scores represent better functional movement quality and movement competency.

    Time frame: Baseline and Week 8

Secondary outcomes

  1. Change from Baseline in Hip Flexion Range of Motion at 8 Weeks

    Active hip flexion range of motion measured in degrees (°) using a universal standard goniometer. Two measurements were obtained for both right and left limbs and averaged. Higher degrees indicate greater joint mobility.

    Time frame: Baseline and week 8

  2. Change from Baseline in Hip Extension Range of Motion at 8 Weeks

    Active hip extension range of motion measured in degrees (°) using a universal standard goniometer. Two measurements were obtained for both right and left limbs and averaged. Higher degrees indicate greater joint mobility.

    Time frame: Baseline and week 8

  3. Change from Baseline in Hip Abduction Range of Motion at 8 Weeks

    Active hip abduction range of motion measured in degrees (°) using a universal standard goniometer. Two measurements were obtained for both right and left limbs and averaged. Higher degrees indicate greater joint mobility.

    Time frame: Baseline and week 8

  4. Change from Baseline in Hip Internal Rotation Range of Motion at 8 Weeks

    Active hip internal rotation range of motion measured in degrees (°) using a universal standard goniometer. Two measurements were obtained for both right and left limbs and averaged. Higher degrees indicate greater joint mobility.

    Time frame: Baseline and week 8

  5. Change from Baseline in Hip External Rotation Range of Motion at 8 Weeks

    Active hip external rotation range of motion measured in degrees (°) using a universal standard goniometer. Two measurements were obtained for both right and left limbs and averaged. Higher degrees indicate greater joint mobility.

    Time frame: Baseline and Week 8

  6. Change from Baseline in Shoulder Hyperextension Range of Motion at 8 Weeks

    Active shoulder hyperextension range of motion measured in degrees (°) using a universal standard goniometer. Two measurements were obtained for both right and left limbs and averaged. Higher degrees indicate greater joint mobility.

    Time frame: Baseline and Week 8

  7. Change from Baseline in Ankle Dorsiflexion Range of Motion at 8 Weeks

    Active ankle dorsiflexion range of motion measured in degrees (°) using a universal standard goniometer. Two measurements were obtained for both right and left limbs and averaged. Higher degrees indicate greater joint mobility.

    Time frame: Baseline and Week 8

  8. Change from Baseline in Ankle Plantar Flexion Range of Motion at 8 Weeks

    Active ankle plantar flexion range of motion measured in degrees (°) using a universal standard goniometer. Two measurements were obtained for both right and left limbs and averaged. Higher degrees indicate greater joint mobility.

    Time frame: Baseline and Week 8

  9. Change from Baseline in Body Fat Percentage at 8 Weeks

    Fat mass percentage measured in percentage (%) using bioelectrical impedance analysis.

    Time frame: Baseline and Week 8

  10. Change from Baseline in Body Weight at 8 Weeks

    Total body weight measured in kilograms (kg).

    Time frame: Baseline and Week 8

  11. Change from Baseline in Body Mass Index (BMI) at 8 Weeks

    Body mass index calculated as body weight divided by height squared (kg/m\^2).

    Time frame: Baseline and Week 8

  12. Change from Baseline in Fat-Free Mass at 8 Weeks

    Fat-free mass measured in kilograms (kg) via bioelectrical impedance analysis.

    Time frame: Baseline and Week 8

07

Study locations

1 site
  • Tokat Gaziosmanpasa University School of Physical Education and Sports
    Tokat Province, Merkez 60100, Turkey (Türkiye)
08

References and documents

Related links

Individual participant data

Plan to share: Yes — De-identified individual participant raw and processed data collected during the study, including Functional Movement Screen (FMS) scores, joint range of motion (ROM) measurements, and body composition parameters, are made publicly available.

Supporting information: Study protocol, Analytic code

Time frame: Data are permanently available in the public domain via the Zenodo repository with no time limitation.

Access criteria: Open access. Anyone interested can freely access and download the datasets and documentation directly from the Zenodo repository without restriction.

Data sharing details ↗ · doi.org

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Apr 2026 to primary completion in Jun 2026, 2 months.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 2, 2026
First posted
Oct 13, 2026
StartActual
Apr 15, 2026
Primary completionActual
Jun 15, 2026
CompletionActual
Jun 30, 2026
Last update
Oct 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 13, 2026
Show all 2 updates
  1. Oct 16, 2026
    Minor edits only
    + 1 other change: conditions
  2. Oct 13, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07869862
Responsible party
Ebru Ersoy (Principal Investigator, Tokat Gaziosmanpasa University) — Principal investigator
First posted
Oct 13, 2026
Start date
Apr 15, 2026
Primary completion
Jun 15, 2026
Completion
Jun 30, 2026
Last update
Oct 16, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion